Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
GDA-201 is composed of ex vivo activated donor natural killer cells, which may have persistent anti-tumor activity (Blood (2019) 134 (Supplement_1): 777).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Elotuzumab + GDA-201||Elotuzumab GDA-201||0||0|
|GDA-201 + Rituximab||GDA-201 Rituximab||0||0|